EBIT: Income before interest and taxes.
Cocrystal Pharma, Inc. (COCP) had EBIT of $-3.49M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$0.10M |
|
$-3.44M |
|
-- |
|
$0.10M |
|
$3.59M |
|
$-3.49M |
|
$0.04M |
|
$-3.44M |
|
$-3.44M |
|
$-3.44M |
|
$-3.44M |
|
$-3.44M |
|
$-3.44M |
|
|
EBIT |
$-3.49M |
$-3.40M |
|
17.42M |
|
17.42M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$5.51M |
|
$0.06M |
|
$1.26M |
|
$6.77M |
|
$3.20M |
|
-- |
|
$0.90M |
|
$4.10M |
|
$2.67M |
|
$2.67M |
|
$2.67M |
|
19.27M |
|
| Cash Flow Statement Financials | |
$-7.15M |
|
-- |
|
$5.00M |
|
$7.10M |
|
$4.95M |
|
$-2.15M |
|
$0.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-3322.86% |
|
-3322.86% |
|
-- |
|
-3280.00% |
|
-3280.00% |
|
$-7.15M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.75 |
|
120.00 |
|
-128.75% |
|
-128.75% |
|
-50.85% |
|
-128.75% |
|
$0.14 |
|
$-0.41 |
|
$-0.41 |
|